Please use this identifier to cite or link to this item:
Title: Impaired kidney function is associated with lower quality of life among community-dwelling older adults The screening for CKD among older people across Europe (SCOPE) study
Author: Artzi-Medvedik, Rada
Kob, Robert
Fabbietti, Paolo
Lattanzio, Fabrizia
Corsonello, Andrea
Melzer, Yehudit
Roller-Wirnsberger, Regina
Wirnsberger, Gerhard
Mattace-Raso, Francesco
Tap, Lisanne
Gil, Pedro
Lainez Martinez, Sara
Formiga Pérez, Francesc
Moreno-Gonzalez, Rafael
Kostka, Tomasz
Guligowska, Agnieszka
Ärnlöv, Johan
Carlsson, Axel C.
Freiberger, Ellen
Melzer, Itshak
SCOPE investigators
Keywords: Insuficiència renal crònica
Qualitat de vida
Persones grans
Chronic renal failure
Quality of life
Older people
Issue Date: 2-Oct-2020
Publisher: BioMed Central
Abstract: Background: Quality of life (QoL) refers to the physical, psychological, social and medical aspects of life that are influenced by health status and function. The purpose of this study was to measure the self-perceived health status among the elderly population across Europe in different stages of Chronic Kidney Disease (CKD). Methods: Our series consisted of 2255 community-dwelling older adults enrolled in the Screening for Chronic Kidney Disease (CKD) among Older People across Europe (SCOPE) study. All patients underwent a comprehensive geriatric assessment (CGA), including included demographics, clinical and physical assessment, number of medications taken, family arrangement, Geriatric Depression Scale (GDS), Cumulative Illness Rating Scale, History of falls, Lower urinary tract symptoms, and Short Physical Performance Battery (SPPB). Estimated glomerular filtration rate (eGFR) was calculated by Berlin Initiative Study (BIS) equation. Quality of life was assessed by Euro Qol questionnaire (Euro-Qol 5D) and EQ-Visual Analogue Scale (EQ-VAS). The association between CKD (eGFR < 60, < 45 ml or < 30 ml/min/1.73m2 ) and low EQoL-VAS was investigated by multivariable logistic regression models. Results: CKD was found to be significantly associated with low EQoL-VAS in crude analysis (OR = 1.47, 95%CI = 1.16– 1.85 for eGFR< 60; OR = 1.38, 95%CI = 1.08–1.77 for eGFR< 45; OR = 1.57, 95%CI = 1.01–2.44). Such association was no longer significant only when adjusting for SPPB (OR = 1.20, 95%CI = 0.93–1.56 for eGFR< 60; OR = 0.87, 95%CI = 0.64– 1.18 for eGFR< 45; OR = 0.84, 95%CI = 0.50–1.42), CIRS and polypharmacy (OR = 1.16, 95%CI = 0.90–1.50 for eGFR< 60; OR = 0.86, 95%CI = 0.64–1.16 for eGFR< 45; OR = 1.11, 95%CI = 0.69–1.80) or diabetes, hypertension and chronic obstructive pulmonary disease (OR = 1.28, 95%CI = 0.99–1.64 for eGFR< 60; OR = 1.16, 95%CI = 0.88–1.52 for eGFR< 45; OR = 1.47, 95%CI = 0.92–2.34). The association between CKD and low EQoL-VAS was confirmed in all remaining multivariable models. Conclusions: CKD may significantly affect QoL in community-dwelling older adults. Physical performance, polypharmacy, diabetes, hypertension and COPD may affect such association, which suggests that the impact of CKD on QoL is likely multifactorial and partly mediated by co-occurrent conditions/risk factors.
Note: Reproducció del document publicat a:
It is part of: BMC Geriatrics, 2020, vol. 20
Related resource:
Appears in Collections:Publicacions de projectes de recerca finançats per la UE
Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
Artzi-MedvedikR.pdf500.82 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons